▲ BUY
4
/ 10
Conviction
$ Value
$49K
Shares
58,060
Price
$1
Filed
Dec 29
▶ Why this score? (4/10)
- ✓ Open market buy (+3)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Cowan Chad
Title
Chief Scientific Officer
CIK
0002039294
Roles
Officer
Transaction Details
Transaction Date
2025-12-22
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
1,045,087
Footnotes
All profits from the reported transactions will be disgorged to the issuer pursuant to applicable requirements. | Shares held by the Cowan Investment Nominee Trust. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.
Filing Info
Cowan Chad's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | IPSC | F | $3K |
| 2026-03-11 | IPSC | F | $4K |
| 2026-02-02 | IPSC | A | $0 |
| 2026-02-02 | IPSC | A | $0 |
| 2026-01-02 | IPSC | F | $2K |
| 2025-12-22 | IPSC | ▲ | $49K ★ |
| 2025-11-20 | IPSC | ▼ | $3K |
| 2025-09-18 | IPSC | A | $0 |
Other Insiders at IPSC (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Carr Douglas
SVP Finance & Operations
|
— | $19K | 2026-03-12 |
|
Russotti Gregory
See Remarks
|
— | $27K | 2026-03-12 |
|
Pfeiffenberger Brent
President and CEO
|
— | — | 2026-03-11 |
|
Cowan Chad
Chief Scientific Officer
|
— | — | 2026-04-01 |
| Murphy Martin Patrick | — | — | 2025-12-09 |